Albany International Declares Dividend
Get Alerts AIN Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.6%
EPS Growth %: +24.6%
Join SI Premium – FREE
PORTSMOUTH, N.H.--(BUSINESS WIRE)-- The Board of Directors of Albany International Corp. (NYSE: AIN) today declared a quarterly dividend of $0.28 per share on the Company’s Class A Common Stock.
The dividend is payable April 7, 2026, to shareholders of record on March 20, 2026.
About Albany International Corp.
Albany is a leading materials science developer and manufacturer of engineered components, using advanced materials processing and automation capabilities, with two core businesses:
- Machine Clothing is the world’s leading producer of custom-designed consumable belts, essential for the manufacture of paper, paperboard, tissue, and towel, as well as pulp, non-wovens, and a variety of other industrial applications.
- Albany Engineered Composites is a growing designer and manufacturer of advanced materials-based engineered components for demanding aerospace applications, supporting both commercial and military platforms.
Albany International is headquartered in Portsmouth, New Hampshire, operates 25 facilities in 12 countries, employs approximately 5,700 people worldwide, and is listed on the New York Stock Exchange (Symbol AIN). Additional information about the Company and its products and services can be found at www.albint.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260227070960/en/
Investor / Media Contact:
Karen Blomquist
Director, Investor Relations
Tel +603.330.2461
EMAIL [email protected]
Source: Albany International Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Twenty West Media Named Official Media Partner of the Americas Food & Beverage Show 30th Anniversary
- Freeman Arts Pavilion Welcome 12,000 to Renovated Venue for 2026 Grand Opening
- Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share